Glenview Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$201M	Sell	6,660,220 -10,059,989	-60%	-$324M	5.43%	5
2025 Q4	$522M	Buy	16,720,209 +27,529	+0.2%	+$678K	11.12%	2
2025 Q3	$337M	Buy	16,692,680 +868,457	+5%	+$15.3M	8.19%	5
2025 Q2	$265M	Buy	15,824,223 +1,045,582	+7%	+$16.9M	7.53%	4
2025 Q1	$227M	Buy	14,778,641 +6,322,317	+75%	+$113M	5.61%	4
2024 Q4	$186M	Hold	8,456,324	–	–	4.71%	5
2024 Q3	$152M	Sell	8,456,324 -701,317	-8%	-$12.3M	3.22%	11
2024 Q2	$149M	Buy	9,157,641 +1,656,357	+22%	+$25.5M	3.15%	12
2024 Q1	$106M	Buy	7,501,284 +5,896,651	+367%	+$74.3M	2.06%	16
2023 Q4	$16.8M	Buy	+1,604,633	New	+$15M	0.39%	34
2016 Q4	–	Sell	-2,176,144	Closed	-$100M	–	52
2016 Q3	$100M	Sell	2,176,144 -906,703	-29%	-$47.3M	0.72%	32
2016 Q2	$155M	Sell	3,082,847 -2,496,465	-45%	-$133M	1.09%	25
2016 Q1	$299M	Sell	5,579,312 -376,484	-6%	-$22.1M	2.18%	16
2015 Q4	$391M	Buy	5,955,796 +1,767,017	+42%	+$109M	2.2%	17
2015 Q3	$236M	Buy	4,188,779 +1,344,379	+47%	+$87.2M	1.17%	31
2015 Q2	$168M	Buy	+2,844,400	New	+$175M	0.67%	48